miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
Lin Chen(Shanghai Medical College of Fudan University), Jianhua Chang(Shanghai Medical College of Fudan University)
Cited by 57
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges
|Cancer Biology and Medicine|2020|95
Apatinib inhibits cellular invasion and migration by fusion kinase KIF5B-RET via suppressing RET/Src signaling pathway
|Oncotarget|2016|55
miRNA expression profile during fluid shear stress-induced osteogenic differentiation in MC3T3-E1 cells
|Chinese Medical Journal|2013|45